As of Jun 02
| -0.0036 / -0.51%|
The 1 analysts offering 12-month price forecasts for Addex Therapeutics Ltd have a median target of 1.07, with a high estimate of 1.07 and a low estimate of 1.07. The median estimate represents a +54.38% increase from the last price of 0.70.
The current consensus among 2 polled investment analysts is to Outperform stock in Addex Therapeutics Ltd. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.